Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Törnblom H[au]:

Management of the multiple symptoms of irritable bowel syndrome. Simrén M et al. Lancet Gastroenterol Hepatol. (2017)

Reply. Simrén M et al. Gastroenterology. (2016)

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Tap J et al. Gastroenterology. (2017)

Search results

Items: 1 to 50 of 100

1.

Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.

Sundin J, Nordlander S, Eutamene H, Alquier-Bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L.

Neurogastroenterol Motil. 2019 Nov;31(11):e13701. doi: 10.1111/nmo.13701. Epub 2019 Sep 13.

PMID:
31518490
2.

The role of diet in irritable bowel syndrome: implications for dietary advice.

Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M.

J Intern Med. 2019 Nov;286(5):490-502. doi: 10.1111/joim.12966. Epub 2019 Aug 29. Review.

PMID:
31468640
3.

Relations between food intake, psychological distress, and gastrointestinal symptoms: A diary study.

Clevers E, Törnblom H, Simrén M, Tack J, Van Oudenhove L.

United European Gastroenterol J. 2019 Aug;7(7):965-973. doi: 10.1177/2050640619839859. Epub 2019 Mar 16.

4.

Anxiety and depression in irritable bowel syndrome: Exploring the interaction with other symptoms and pathophysiology using multivariate analyses.

Midenfjord I, Polster A, Sjövall H, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2019 Aug;31(8):e13619. doi: 10.1111/nmo.13619. Epub 2019 May 5.

PMID:
31056802
5.

Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.

Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J.

Gastroenterology. 2019 Aug;157(2):391-402.e2. doi: 10.1053/j.gastro.2019.04.019. Epub 2019 Apr 22.

PMID:
31022401
6.

Visceral sensitivity remains stable over time in patients with irritable bowel syndrome, but with individual fluctuations.

Josefsson A, Rosendahl A, Jerlstad P, Näslin G, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2019 Jul;31(7):e13603. doi: 10.1111/nmo.13603. Epub 2019 Apr 22.

PMID:
31012215
7.

Fasting breath H2 and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome.

Le Nevé B, Derrien M, Tap J, Brazeilles R, Cools Portier S, Guyonnet D, Ohman L, Störsrud S, Törnblom H, Simrén M.

PLoS One. 2019 Apr 4;14(4):e0214273. doi: 10.1371/journal.pone.0214273. eCollection 2019.

8.

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.

Labus JS, Osadchiy V, Hsiao EY, Tap J, Derrien M, Gupta A, Tillisch K, Le Nevé B, Grinsvall C, Ljungberg M, Öhman L, Törnblom H, Simren M, Mayer EA.

Microbiome. 2019 Mar 21;7(1):45. doi: 10.1186/s40168-019-0656-z.

9.

Within- and Between-Subject Variation in Dietary Intake of Fermentable Oligo-, Di-, Monosaccharides, and Polyols Among Patients with Irritable Bowel Syndrome.

Nybacka S, Störsrud S, Liljebo T, Le Nevé B, Törnblom H, Simrén M, Winkvist A.

Curr Dev Nutr. 2018 Dec 24;3(2):nzy101. doi: 10.1093/cdn/nzy101. eCollection 2019 Feb.

10.

Effects of the long-term storage of human fecal microbiota samples collected in RNAlater.

Tap J, Cools-Portier S, Pavan S, Druesne A, Öhman L, Törnblom H, Simren M, Derrien M.

Sci Rep. 2019 Jan 24;9(1):601. doi: 10.1038/s41598-018-36953-5.

11.

Oesophageal symptoms are common and associated with other functional gastrointestinal disorders (FGIDs) in an English-speaking Western population.

Josefsson A, Palsson O, Simrén M, Sperber AD, Törnblom H, Whitehead W.

United European Gastroenterol J. 2018 Dec;6(10):1461-1469. doi: 10.1177/2050640618798894. Epub 2018 Sep 6.

12.

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects.

Sundin J, Stridsberg M, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L.

Sci Rep. 2018 Nov 14;8(1):16821. doi: 10.1038/s41598-018-35241-6.

13.

Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders.

Törnblom H, Drossman DA.

Curr Gastroenterol Rep. 2018 Nov 5;20(12):58. doi: 10.1007/s11894-018-0664-3. Review.

14.

Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.

Polster AV, Palsson OS, Törnblom H, Öhman L, Sperber AD, Whitehead WE, Simrén M.

Neurogastroenterol Motil. 2019 Jan;31(1):e13483. doi: 10.1111/nmo.13483. Epub 2018 Nov 4.

PMID:
30393924
15.

Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.

Törnblom H, Goosey R, Wiseman G, Baker S, Emmanuel A.

United European Gastroenterol J. 2018 Nov;6(9):1417-1427. doi: 10.1177/2050640618787648. Epub 2018 Jul 9.

16.

Reply.

Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):1002-1004. doi: 10.1016/j.cgh.2018.10.009. Epub 2018 Oct 10. No abstract available.

PMID:
30315945
17.

Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.

Frändemark Å, Törnblom H, Jakobsson S, Simrén M.

Am J Gastroenterol. 2018 Oct;113(10):1540-1549. doi: 10.1038/s41395-018-0262-x. Epub 2018 Sep 25.

PMID:
30254230
18.

Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.

Bennet SMP, Sundin J, Magnusson MK, Strid H, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L.

Neurogastroenterol Motil. 2018 Dec;30(12):e13468. doi: 10.1111/nmo.13468. Epub 2018 Sep 17.

PMID:
30230134
19.

Funding for gastrointestinal disease research in the European Union.

Törnblom H, Simrén M, Barbara G, Niesler B.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):593-595. doi: 10.1016/S2468-1253(18)30203-6. Epub 2018 Aug 8. No abstract available. Erratum in: Lancet Gastroenterol Hepatol. 2018 Oct;3(10):e5.

PMID:
30102177
20.

Pre- and perinatal stress and irritable bowel syndrome in young adults - A nationwide register-based cohort study.

Olén O, Stephansson O, Backman AS, Törnblom H, Simrén M, Altman M.

Neurogastroenterol Motil. 2018 Nov;30(11):e13436. doi: 10.1111/nmo.13436. Epub 2018 Aug 7.

PMID:
30084125
21.

How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.

Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M.

Am J Gastroenterol. 2018 Jul;113(7):1017-1025. doi: 10.1038/s41395-018-0074-z. Epub 2018 Jun 8.

PMID:
29880963
22.

Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults.

Aziz I, Palsson OS, Whitehead WE, Sperber AD, Simrén M, Törnblom H.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):878-886. doi: 10.1016/j.cgh.2018.05.020. Epub 2018 May 29.

PMID:
29857155
23.

Neither self-reported atopy nor IgE-mediated allergy are linked to gastrointestinal symptoms in patients with irritable bowel syndrome.

Nybacka S, Öhman L, Störsrud S, Mybeck M, Böhn L, Wilpart K, Winkvist A, Bengtsson U, Törnblom H, Simrén M.

Neurogastroenterol Motil. 2018 Oct;30(10):e13379. doi: 10.1111/nmo.13379. Epub 2018 Jun 1.

PMID:
29856100
24.

Systemic cytokines are elevated in a subset of patients with irritable bowel syndrome but largely unrelated to symptom characteristics.

Bennet SMP, Palsson O, Whitehead WE, Barrow DA, Törnblom H, Öhman L, Simrén M, van Tilburg MAL.

Neurogastroenterol Motil. 2018 Oct;30(10):e13378. doi: 10.1111/nmo.13378. Epub 2018 May 24.

PMID:
29797382
25.

Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.

Pohl D, Van Oudenhove L, Törnblom H, Le Nevé B, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1745-1753.e1. doi: 10.1016/j.cgh.2018.04.034. Epub 2018 Apr 24.

PMID:
29702295
26.

Abnormal small bowel motility in patients with hereditary transthyretin amyloidosis.

Wixner J, Törnblom H, Karling P, Anan I, Lindberg G.

Neurogastroenterol Motil. 2018 Sep;30(9):e13354. doi: 10.1111/nmo.13354. Epub 2018 Apr 14.

PMID:
29655299
27.

Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders.

Keller J, Bassotti G, Clarke J, Dinning P, Fox M, Grover M, Hellström PM, Ke M, Layer P, Malagelada C, Parkman HP, Scott SM, Tack J, Simren M, Törnblom H, Camilleri M; International Working Group for Disorders of Gastrointestinal Motility and Function.

Nat Rev Gastroenterol Hepatol. 2018 May;15(5):291-308. doi: 10.1038/nrgastro.2018.7. Epub 2018 Apr 6. Review.

28.

Heart rate variability characteristics of patients with irritable bowel syndrome and associations with symptoms.

Polster A, Friberg P, Gunterberg V, Öhman L, Le Nevé B, Törnblom H, Cvijovic M, Simren M.

Neurogastroenterol Motil. 2018 Jul;30(7):e13320. doi: 10.1111/nmo.13320. Epub 2018 Mar 25.

PMID:
29575352
29.

Health problems associated with irritable bowel syndrome: analysis of a primary care registry.

Clevers E, Vaes B, Henrard S, Goderis G, Tack J, Törnblom H, Simrén M, Van Oudenhove L.

Aliment Pharmacol Ther. 2018 May;47(10):1349-1357. doi: 10.1111/apt.14612. Epub 2018 Mar 24.

30.

ABC om - IBS – irritabel tarm.

Lagerlöf E, Agreus L, Simrén M, Törnblom H.

Lakartidningen. 2018 Mar 7;115. pii: EXDU. Swedish. No abstract available.

31.

Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome.

Grinsvall C, Törnblom H, Tack J, Van Oudenhove L, Simrén M.

United European Gastroenterol J. 2018 Mar;6(2):300-309. doi: 10.1177/2050640617715851. Epub 2017 Jun 20.

32.

Factor Analysis Defines Distinct Upper and Lower Gastrointestinal Symptom Groups Compatible With Rome IV Criteria in a Population-based Study.

Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1252-1259.e5. doi: 10.1016/j.cgh.2018.02.042. Epub 2018 Mar 3.

PMID:
29510215
33.

Development of Irritable Bowel Syndrome Features Over a 5-year Period.

Clevers E, Tack J, Törnblom H, Ringström G, Luyckx K, Simrén M, Van Oudenhove L.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1244-1251.e1. doi: 10.1016/j.cgh.2018.02.043. Epub 2018 Mar 3.

PMID:
29510214
34.

Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.

Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252-262. doi: 10.1016/S2468-1253(18)30003-7. Epub 2018 Feb 1.

PMID:
29396034
35.

Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial.

Tack J, Pokrotnieks J, Urbonas G, Banciu C, Yakusevich V, Bunganic I, Törnblom H, Kleban Y, Eavis P, Tsuchikawa M, Miyagawa T.

Neurogastroenterol Motil. 2018 Jun;30(6):e13284. doi: 10.1111/nmo.13284. Epub 2018 Jan 8.

PMID:
29315999
36.

Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.

Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L.

Gastroenterology. 2018 Mar;154(4):1140-1171.e1. doi: 10.1053/j.gastro.2017.11.279. Epub 2017 Dec 22. Review.

PMID:
29274869
37.

The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M.

Am J Gastroenterol. 2018 Jan;113(1):86-96. doi: 10.1038/ajg.2017.421. Epub 2017 Nov 14.

PMID:
29134969
38.

Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.

Vork L, Keszthelyi D, Mujagic Z, Kruimel JW, Leue C, Pontén I, Törnblom H, Simrén M, Albu-Soda A, Aziz Q, Corsetti M, Holvoet L, Tack J, Rao SS, van Os J, Quetglas EG, Drossman DA, Masclee AAM.

Neurogastroenterol Motil. 2018 Mar;30(3). doi: 10.1111/nmo.13244. Epub 2017 Nov 6.

PMID:
29106029
39.

Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation? Authors' reply.

Polster A, Van Oudenhove L, Jones M, Öhman L, Törnblom H, Simrén M.

Aliment Pharmacol Ther. 2017 Oct;46(7):698-699. doi: 10.1111/apt.14260. No abstract available.

40.

Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts.

Tack J, Corsetti M, Camilleri M, Quigley EM, Simren M, Suzuki H, Talley NJ, Tornblom H, Van Oudenhove L.

Gut. 2018 Aug;67(8):1425-1433. doi: 10.1136/gutjnl-2016-312230. Epub 2017 Aug 16.

PMID:
28814481
41.

Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.

Polster A, Van Oudenhove L, Jones M, Öhman L, Törnblom H, Simrén M.

Aliment Pharmacol Ther. 2017 Sep;46(5):529-539. doi: 10.1111/apt.14207. Epub 2017 Jul 3. Erratum in: Aliment Pharmacol Ther. 2018 Apr;47(7):1049.

42.

Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.

Bennet SMP, Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Öhman L, Simrén M.

Gut. 2018 May;67(5):872-881. doi: 10.1136/gutjnl-2016-313128. Epub 2017 Apr 17.

PMID:
28416515
43.

Management of the multiple symptoms of irritable bowel syndrome.

Simrén M, Törnblom H, Palsson OS, Whitehead WE.

Lancet Gastroenterol Hepatol. 2017 Feb;2(2):112-122. doi: 10.1016/S2468-1253(16)30116-9. Epub 2017 Jan 12. Review.

PMID:
28403981
44.

Coping Skills Are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome.

Wilpart K, Törnblom H, Svedlund J, Tack JF, Simrén M, Van Oudenhove L.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1565-1571.e3. doi: 10.1016/j.cgh.2017.02.032. Epub 2017 Mar 7.

PMID:
28286196
45.

Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?

Aziz I, Törnblom H, Simrén M.

Curr Opin Gastroenterol. 2017 May;33(3):196-202. doi: 10.1097/MOG.0000000000000348. Review.

PMID:
28257307
46.

Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management.

Törnblom H, Drossman DA.

Handb Exp Pharmacol. 2017;239:417-440. doi: 10.1007/164_2016_106. Review.

PMID:
28204956
47.

Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts.

Simrén M, Törnblom H, Palsson OS, van Tilburg MAL, Van Oudenhove L, Tack J, Whitehead WE.

Gut. 2018 Feb;67(2):255-262. doi: 10.1136/gutjnl-2016-312361. Epub 2017 Jan 19.

PMID:
28104632
48.
49.

Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.

Vanheel H, Carbone F, Valvekens L, Simren M, Tornblom H, Vanuytsel T, Van Oudenhove L, Tack J.

Am J Gastroenterol. 2017 Jan;112(1):132-140. doi: 10.1038/ajg.2016.499. Epub 2016 Dec 13.

PMID:
27958284
50.

Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, Störsrud S, Le Nevé B, Öhman L, Simrén M.

Gastroenterology. 2017 Jan;152(1):111-123.e8. doi: 10.1053/j.gastro.2016.09.049. Epub 2016 Oct 7.

Supplemental Content

Loading ...
Support Center